Is PRA-rcd3 relevant to Akitas?
No — this specific mutation is documented in Cardigan Welsh Corgis, not established as the Akita form of PRA.
Quick answer
Is PRA-rcd3 relevant to Akitas?
No — this specific mutation is documented in Cardigan Welsh Corgis, not established as the Akita form of PRA.
Progressive retinal atrophy comes in several distinct genetic forms, each tied to a specific mutation documented in specific breeds — and rcd3 happens to be one identified in Cardigan Welsh Corgis, not Akitas.

Owners who've encountered 'PRA-rcd3' in genetic testing panels or general research and are trying to figure out whether it's relevant to their Akita specifically are the audience here.
This guide is not medical advice. If your dog shows pain, sudden behavior change, or worsening symptoms, consult a licensed veterinarian.
Some links may be affiliate links. We may earn a commission at no extra cost to you. We only suggest products we believe are helpful for dog owners.
Check this first
Regardless of which specific genetic form might eventually be relevant, sudden, complete vision loss over hours to a day or two is different from typical PRA progression and warrants prompt veterinary evaluation, since it may indicate a different, sometimes treatable cause.
Gradual night-vision difficulty or slow overall vision decline, consistent with general PRA as documented in Akitas, is not an emergency — it warrants a scheduled ophthalmology evaluation, including an electroretinogram, to assess actual retinal function directly.
The practical point for an Akita owner is that clinical eye testing (an electroretinogram) is more directly informative for this breed than focusing specifically on the rcd3 genetic marker, since that particular mutation isn't the established cause of PRA in Akitas.
If any of these apply, call your vet or an emergency clinic now. The rest of this page is for the cases that are not an emergency.
PRA-rcd3 refers to a specific genetic mutation causing retinal degeneration that's documented and characterized in the Cardigan Welsh Corgi, not established as the relevant form for Akitas. While general progressive retinal atrophy is clearly documented as a common Akita health concern, this particular genetic subtype isn't the established cause in this breed, making clinical eye testing more directly useful than focusing on this one genetic marker.
PRA-rcd3 specifically is documented in Cardigan Welsh Corgis; there's no established pattern of this particular mutation occurring in Akitas, even though general PRA is a recognized and relatively more common concern for the breed overall.
The Akita's genuinely relevant breed connection is to progressive retinal atrophy broadly, which is specifically named among its documented common health issues. The rcd3 mutation itself reflects Corgi-specific genetics rather than anything characterized in Akita bloodlines, which is why an Akita's actual retinal risk is better assessed through clinical testing than by focusing on this one unrelated genetic marker.
Because this specific genetic subtype isn't relevant to Akitas, there are no meaningful environmental considerations to discuss for it in this breed. General PRA in Akitas, like other genetic eye conditions, isn't influenced by lifestyle or environment, though a stable home environment supports better adaptation if vision loss from any cause does develop.
Schedule an ophthalmology evaluation, including an electroretinogram, for any gradual vision changes rather than relying on a single genetic marker result. Seek prompt care for sudden, complete vision loss, which may have a different and sometimes treatable cause.
PRA genetic testing panels often screen for multiple breed-specific mutations at once, which can create confusion about which results actually matter for a given breed. Avoid these mistakes.
See all Akita health problems, which breeds are prone to progressive retinal atrophy pra rcd3, or the full Akita breed guide for temperament, exercise needs and ownership costs.
Because this specific mutation isn't relevant to Akitas, there's no meaningful breed-specific timeline to track for it. General PRA in this breed, when it occurs, typically progresses over months to a couple of years, similar to other documented forms.
Success is understanding which specific test results actually matter for an Akita and pursuing the clinical eye exam that gives the most directly relevant information about this breed's real, documented retinal health risk.
When a broad genetic health panel came back with results for several PRA subtypes, including rcd3, Toby wasn't sure what any of it meant for his Akita, Bandit, in Wichita. He brought the results to his vet, who explained that rcd3 was actually a Corgi-documented mutation and not established as relevant to Akitas. Instead, Toby's vet recommended a clinical electroretinogram exam with a veterinary ophthalmologist, which more directly assessed Bandit's actual retinal function. The exam came back normal, giving Toby more meaningful reassurance than the unrelated genetic panel result had.
Key takeaway: A genetic panel testing for mutations across many breeds can return confusing or irrelevant results — a clinical eye exam gives more directly useful information for a breed whose specific PRA genetics aren't the ones being tested.
No — this particular genetic mutation is documented and characterized in the Cardigan Welsh Corgi. The Akita is separately and clearly documented as predisposed to PRA generally, but not specifically to this genetic subtype.
Not at all — general progressive retinal atrophy is specifically named among the Akita's documented common health issues; it's just that the exact genetic mutation involved in Akita cases isn't established as the same rcd3 mutation found in Corgis.
Broad commercial genetic testing panels often screen for many known breed-specific mutations across dozens of breeds in a single test, which can return results for mutations that aren't actually relevant to a given dog's breed.
A clinical eye exam, including an electroretinogram from a veterinary ophthalmologist, is the most directly relevant way to assess an Akita's actual retinal health, since the specific causative genetic mutation for Akita PRA isn't the well-characterized rcd3 form.
The genetics of PRA in Akitas specifically are less thoroughly characterized in publicly available research compared to some other breeds' well-mapped mutations, which is part of why clinical testing remains particularly important for this breed.
This would be an unusual and worth discussing with a veterinary geneticist or genetic counselor, since rcd3 isn't the mutation documented as causing PRA in this breed — a mixed-breed ancestry or panel testing artifact might be relevant to explore.
Prioritize a clinical ophthalmology exam over any single genetic marker result, and treat general PRA (not the rcd3 subtype specifically) as the relevant, documented breed risk to discuss with your vet.
No — this specific mutation is documented in Cardigan Welsh Corgis, not established as the Akita form of PRA.
Yes — general progressive retinal atrophy is specifically documented as a common Akita health issue, just not this particular genetic subtype.
A clinical electroretinogram exam from a veterinary ophthalmologist is more directly informative than a single genetic marker not established for this breed.
Typically $300 to $600 through a veterinary ophthalmologist.
It's common for broad panels to test for many breeds' mutations; discuss unclear results with a genetic counselor or your vet.
A one-page prep sheet for this condition: the signs, the questions to ask, what to get priced. Unlocks here.
You get: Vet visit prep sheet
No spam. One-click unsubscribe. See our privacy policy.
Preview page 1 before you decide.





